期刊文献+

药物性肾损害的研究进展 被引量:14

Research progress in drug-induced kidney injury
下载PDF
导出
摘要 药物性肾损害是药物不良反应的重要方面之一,其发生率不断增高,对常规治疗及患者预后都有不利影响。本文根据国内、外最新研究进展,就药物性肾损害的机制、常见的可致肾损害的药物以及对药物性肾损害的诊断、预防和治疗措施作一概述。 The drug-induced kidney injury is one of the important aspects of the adverse drug reactions whose occurrence rate constantly increases, which have an adverse impact on the regular treatment and prognosis of patients. This paper summarizes the mechanisms of drug-induced kidney injury and introduces the common drugs that may cause kidney injury, diagnosis, prevention and treatment of the drag-induced kidney injury according to the latest research progress at home and abroad.
作者 邓博 丁峰
出处 《上海医药》 CAS 2013年第1期10-14,共5页 Shanghai Medical & Pharmaceutical Journal
基金 国家自然科学基金项目(项目编号:81070609) 国家自然科学基金项目(项目编号:81270850) 上海市科学技术委员会重点项目(项目编号:11441901400)
关键词 药物性肾损害 机制 预防 治疗 drug-induced kidney injury mechanism prevention treatment
  • 相关文献

参考文献11

  • 1Fanos V, Cataldi L. Drug misadventuring in neonatal nephrology [J]. Pediatr Med Chit, 2002, 24(2): 150-156.
  • 2孙海鸥,胡伟新.药物性肾损害的机制及其临床表现[J].肾脏病与透析肾移植杂志,2006,15(3):252-257. 被引量:12
  • 3Schneider V, Levesque LE, Zhang B, et al. Association of selective and conventional nonsteroidal anti-inflammatory drugs with acute renal failure: a population-based, nested case-control analysis [J]. Am J Epidemiol, 2006, 164(9): 881- 889.
  • 4Costiniuk CT, McCarthy AE, Talreia H, et al. Acute renal failure and disseminated intravascular coagulation associated with rifampin in tuberculosis treatment [J]. Int J Tuberc Lung Dis, 2011, 15(3): 421.
  • 5Herlitz LC, Mohan S, Stokes MB, et al. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities [J]. Kidney Int, 2010, 78(11): 1171-1177.
  • 6Laniado-Laborin R, Cabrales-Vargas MN. Amphotericin B: side effects and toxicity [J]. Rev Iberoam Micol, 2009, 26(4): 223-227.
  • 7Lameire N, Kruse V, Rottey S. Nephrotoxicity of anticancer drugs - an underestimated problem? [J]. Acta Clin Belq, 2011, 66(5): 337-345.
  • 8Miller RP, Tadagavadi RK, Ramesh G, et al. Mechanisms of cisplatin nephrotoxicity [J]. Toxins (Basel), 2010, 2(11): 2490-2518.
  • 9Perazella MA, Moeckel GW. Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy [J]. Semin Nephrol, 2010, 30(6): 570-581.
  • 10Gurevich F, Perazella MA. Renal effects of anti-angiogenesis therapy: update for the internist [J]. Am J Med, 2009, 122(4): 322-328.

二级参考文献13

  • 1Kleinknecht D,Landais P,Goldfarb.Drug-associated acute renal failure:a prospective collaborative study of 81 biopsied patients.Adv Exp Med Biol,1987,212:125-128.
  • 2Perazella MA.COX-2 selective inhibitors:Analysis of renal effects.Expert Opin.Drug Saf,2002,1:53-64.
  • 3Perazella MA,Tray K.Selective cyclooxygenase-2 inhibitors:A pattern of nephrotoxicity similar to traditional nonsteroidal anti-inflammatory drugs.Am J Med,2001,111:64 -67.
  • 4Pison R,Ruggenenti P,Remuzzi G.Drug-induced thrombotic microangiopathy:incidence,prevention and management.Drug Saf,2001,24:491 -501.
  • 5Venkat KK,Tkach D,Kupin W,et al.Reversal of cyclosporineassociated hemolytic uremic syndrome by plasma exchange with fresh-frozen plasma replacement in renal transplant recipients.Transplant Proc,1991,23:1256-1257.
  • 6Trimarchi HM,Truong LD,Brennan S,et al.FK506-associated thrombotic microangiopathy:report of two cases and review of the literature.Transplantation,1999,67:539 -544.
  • 7Gibbs WJ,Drew RH,Perfect JR.Liposomal amphotericin B:clinical experience and perspectives.Expert Rev Anti Infect Ther,2005,3:167-181.
  • 8Briguori C,Airoldi F,Morici N,et al.New pharmacological protocols to prevent or reduce contrast media nephropathy.Minerva Cardioangio,2005,53:49 -58.
  • 9Stone GW,McCullough PA,Tumlin JA,et al.Fenoldopam mesylate for the prevention of contrast-induced nephropathy:a randomized controlled trial.JAMA,2003,290:2284-2291.
  • 10Markowitz GS,Appel GB,Fine PL,et al.Collapsing focal segmental glomerulosclerosis following treatment with high dose pamidronate.J Am Soc Nephrol,2001,12:1164-1172.

共引文献11

同被引文献244

引证文献14

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部